{"id":96580,"date":"2023-10-04T07:00:00","date_gmt":"2023-10-04T00:00:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2023100407000096580"},"modified":"2023-10-08T16:31:24","modified_gmt":"2023-10-08T08:31:24","slug":"%e7%be%8e%e5%9b%bd%e8%8d%af%e7%9b%91%e5%b1%80fda%e6%89%b9%e5%87%86%e5%88%9b%e8%83%9c%e9%9b%86%e5%9b%a2%e5%bc%80%e5%b1%95osemitamab-tst001%e4%bd%9c%e4%b8%ba%e8%83%83%e7%99%8c%e6%88%96%e8%83%83","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2023100407000096580","title":{"rendered":"\u7f8e\u56fd\u836f\u76d1\u5c40(FDA)\u6279\u51c6\u521b\u80dc\u96c6\u56e2\u5f00\u5c55Osemitamab (TST001)\u4f5c\u4e3a\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c\u60a3\u8005\u7684\u4e00\u7ebf\u6cbb\u7597\u7684\u5168\u7403III\u671f\u8bd5\u9a8c"},"content":{"rendered":"<p class=\"prntac\"><span id=\"spanHghlt4ca0\">Osemitamab (TST001)\u6709\u671b\u6210\u4e3a\u5168\u7403\u7597\u6cd5\uff0c\u63d0\u5347HER2\u9634\u6027\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c\u60a3\u8005\u7684\u5f53\u524d\u6cbb\u7597\u6807\u51c6\u3002<\/span><\/p>\n<p><p><span class=\"legendSpanClass\">\u7f8e\u56fd\u65b0\u6cfd\u897f\u5dde\u666e\u6797\u65af\u987f\u548c\u4e2d\u56fd\u82cf\u5dde<\/span><span class=\"legendSpanClass\">2023\u5e7410\u67084\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212;&nbsp;\u521b\u80dc\u96c6\u56e2(06628.HK)\uff0c\u4e00\u5bb6\u5177\u5907\u751f\u7269\u836f\u54c1\u53d1\u73b0\u3001\u7814\u53d1\u3001\u5de5\u827a\u5f00\u53d1\u548c\u751f\u4ea7\u5168\u6d41\u7a0b\u6574\u5408\u80fd\u529b\u7684\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u5ba3\u5e03\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40(FDA)\u5df2\u6279\u51c6\u516c\u53f8\u5f00\u5c55Osemitamab (TST001)\u8054\u5408\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u53ca\u5316\u7597\u4f5c\u4e3aHER2\u9634\u6027\u3001CLDN18.2\u8868\u8fbe\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c(G\/GEJ)\u60a3\u8005\u4e00\u7ebf\u6cbb\u7597\u7684TranStar 301\u5168\u7403III\u671f\u5173\u952e\u6027\u8bd5\u9a8c\u3002\u83b7\u5f97\u8be5\u540c\u610f\u6807\u5fd7\u7740Osemitamab (TST001)\u7684\u5168\u7403\u5f00\u53d1\u83b7\u5f97\u91cd\u5927\u8fdb\u5c55\uff0c\u4e5f\u662f\u7ee72023\u5e747\u6708Osemitamab (TST001)\u7684III\u671f\u5173\u952e\u6027\u8bd5\u9a8c\u83b7\u4e2d\u56fd\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u836f\u54c1\u5ba1\u8bc4\u4e2d\u5fc3(CDE)\u548c\u97e9\u56fdMFDS\u6279\u51c6\u540e\u7684\u53c8\u4e00\u4e2a\u91cd\u8981\u91cc\u7a0b\u7891\u3002&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p>\u8fd9\u4e00\u91cc\u7a0b\u7891\u6807\u5fd7\u7740Osemitamab (TST001)\u5728\u5411\u5168\u7403\u7597\u6cd5\u8fc8\u8fdb\u7684\u8fc7\u7a0b\u4e2d\u53d6\u5f97\u4e86\u91cd\u8981\u8fdb\u5c55\uff0c\u4ece\u800c\u63d0\u5347\u4e86HER2\u9634\u6027\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8(G\/GEJ)\u817a\u764c\u60a3\u8005\u7684\u5f53\u524d\u6cbb\u7597\u6807\u51c6\u3002\u901a\u8fc7\u7279\u5f02\u6027\u9776\u5411CLDN18.2\u5e76\u5c06\u5176\u8054\u5408\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u53ca\u5316\u7597\uff0cOsemitamab (TST001)\u6709\u671b\u91cd\u5851\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c\u7684\u6cbb\u7597\u6a21\u5f0f\u3002<\/p>\n<p>\u80c3\u764c\u5728\u5168\u7403\u8303\u56f4\u5185\u4ecd\u7136\u662f\u4e00\u79cd\u5e38\u89c1\u764c\u75c7\uff0c\u4e8e2020\u5e74\u9020\u6210\u8d85\u8fc7\u4e00\u767e\u4e07\u5b97\u65b0\u75c5\u4f8b\uff0c\u4f30\u8ba1\u6709769,000\u4eba\u6b7b\u4ea1\uff08\u76f8\u5f53\u4e8e\u5168\u7403\u6bcf13\u4f8b\u6b7b\u4ea1\u75c5\u4f8b\u4e2d\u5c31\u67091\u4f8b\u6b7b\u4e8e\u80c3\u764c\uff09\uff0c\u5168\u7403\u53d1\u75c5\u7387\u6392\u540d\u7b2c\u4e94\uff0c\u6b7b\u4ea1\u7387\u6392\u540d\u7b2c\u56db<sup>1<\/sup>\u3002\u94c2\u7c7b\u548c\u6c1f\u5c3f\u5627\u5576\u8054\u5408\u7597\u6cd5\u662fHER2 \u9634\u6027\u665a\u671f\u80c3\u764c\u60a3\u8005\u7684\u4e3b\u8981\u5316\u7597\u65b9\u6848<sup>2<\/sup>\u3002\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u88ab\u6279\u51c6\u4e0e\u5316\u7597\u8054\u5408\u7528\u4e8e\u665a\u671f\u6216\u8f6c\u79fb\u6027\u80c3\u764c\u60a3\u8005\u7684\u4e00\u7ebf\u6cbb\u7597\u3002\u5c3d\u7ba1\u6cbb\u7597\u7ed3\u679c\u6709\u6240\u6539\u5584\uff0c\u4f46\u63a5\u53d7\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u52a0\u5316\u7597\u7684\u60a3\u8005\u4e2d\u4f4d\u603b\u751f\u5b58\u671f\u4ecd\u5c11\u4e8e14\u4e2a\u6708<sup>3<\/sup>\u3002<\/p>\n<p>Osemitamab (TST001)\u662f\u7b2c\u4e8c\u4ee3\u9776\u5411CLDN18.2\u7684\u4eba\u6e90\u5316\u6297\u4f53\uff0c\u5177\u6709\u6539\u5584\u7684CLDN18.2\u7ed3\u5408\u4eb2\u548c\u529b\u548c\u589e\u5f3a\u7684\u6297\u4f53\u4f9d\u8d56\u6027\u7ec6\u80de\u6bd2\u6027\uff08ADCC\uff09\u3002\u5176\u5728\u5177\u6709\u5e7f\u6cdbCLDN18.2\u8868\u8fbe\u7684\u4e34\u5e8a\u524d\u80bf\u7624\u6a21\u578b\u4e2d\u663e\u793a\u51fa\u6297\u80bf\u7624\u6d3b\u6027\u3002<\/p>\n<p>\u4e3a\u652f\u6301\u5168\u7403III\u671f\u8bd5\u9a8c\u7533\u8bf7\u53caFDA\u7684\u4e34\u5e8aII\u671f\u7ed3\u675f\u4f1a\u8bae(EOP2)\uff0c\u521b\u80dc\u96c6\u56e2\u5df2\u5728\u7f8e\u56fd\u53ca\u4e2d\u56fd\u540c\u65f6\u8fdb\u884c\u4e86Osemitamab (TST001)\u8054\u5408\u5316\u7597\u6216\u8054\u5408\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u4e0e\u5316\u7597\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5e76\u8bbe\u7f6e\u4e86\u591a\u4e2a\u5242\u91cf\u7ec4\uff0c\u4ee5\u4f18\u5316III\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5242\u91cf\u3002\u6b64\u5916\uff0c\u516c\u53f8\u8fd8\u4e0e\u7f8e\u56fd\u4e00\u5bb6\u7ecf\u9a8c\u4e30\u5bcc\u7684\u4f34\u968f\u8bca\u65ad\u5408\u4f5c\u4f19\u4f34\u5408\u4f5c\uff0c\u5171\u540c\u5f00\u53d1\u4e86\u4e00\u79cd\u53ef\u7279\u5f02\u6027\u8bc6\u522bCLDN18.2\u7684\u4f34\u968f\u8bca\u65ad\u8bd5\u5242\u76d2\u3002<\/p>\n<p>\u4e8e2023 \u5e74ASCO \u5e74\u4f1a\u53ca2023 \u5e74ESMO GI \u4f1a\u8bae\u4e0a\uff0c\u521b\u80dc\u96c6\u56e2\u5448\u62a5\u4e86Osemitamab (TST001)\u8054\u5408CAPOX\u4f5c\u4e3a\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c\u4e00\u7ebf\u6cbb\u7597\u7684\u4ee4\u4eba\u9f13\u821e\u7684\u7597\u6548\u6570\u636e\u3002\u5728\u5242\u91cf\u9012\u589e\u53ca\u5242\u91cf\u6269\u5c55\u7ec4\u4e2d\uff0c\u5171\u670964\u540d\u60a3\u8005\u5165\u7ec4\u5e76\u63a5\u53d7Osemitamab (TST001)\u6cbb\u7597\uff0c\u5242\u91cf\u8303\u56f4\u4e3a1\u81f38mg\/kg Q3W\u3002\u7597\u6548\u6269\u5c55\u8981\u6c42CLDN18.2\u9633\u6027\uff08\u5373\u7528LDT\u65b9\u6cd5\u226510%\u80bf\u7624\u7ec6\u80de\u7684CLDN18.2 IHC\u819c\u67d3\u8272\u5f3a\u5ea6\u22651+\uff0c\u7b5b\u9009\u51fa\u7ea655%\u7684\u7b5b\u9009\u60a3\u8005\uff09\u3002<span id=\"spanHghltd18e\">\u6570\u636e\u663e\u793a\uff0c\u6240\u6709\u5242\u91cf\u7ec4\u7684\u9884\u8ba1\u4e2d\u4f4d\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\uff08DOR)\u4e3a9.9\u4e2a\u6708\uff0c\u4e2d\u4f4d\u65e0\u8fdb\u5c55\u751f\u5b58\u671f(PFS)\u4e3a9.5\u4e2a\u6708<\/span>\u3002<span id=\"spanHghlt1c49\">\u5728\u6269\u5c55\u9636\u6bb5\uff0c\u4ee56mg\/kg Q3W\u5242\u91cf\u6cbb\u7597\u768449\u540d\u60a3\u8005\u7684mDOR \u53camPFS\u6570\u636e\u5c06\u4e8e2023\u5e74ESMO\u4e0a\u5448\u62a5\u3002<\/span>\u8be5\u7b49\u6570\u636e\u4ea6\u663e\u793a\uff0c\u53d7\u76ca\u4e8e\u5728\u6807\u51c6\u6cbb\u7597\u4e2d\u52a0\u5165Osemitamab (TST001)\u7684CLDN18.2\u9633\u6027\u60a3\u8005\u53ef\u80fd\u5360\u6240\u6709\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c\u768455%\u4ee5\u4e0a\u3002<\/p>\n<p>\u521b\u80dc\u96c6\u56e2\u5168\u7403\u836f\u7269\u5f00\u53d1\u6267\u884c\u526f\u603b\u88c1\uff0c\u9996\u5e2d\u533b\u5b66\u5b98Caroline Germa\u535a\u58eb\u8868\u793a\uff0c&quot;\u6211\u4eec\u5bf9EOP2\u4f1a\u8bae\u53d6\u5f97\u7684\u79ef\u6781\u6210\u679c\u611f\u5230\u9ad8\u5174\uff0c\u6211\u4eec\u63d0\u4ea4\u7684\u4e2d\u671f\u5b89\u5168\u6027\u3001\u4e34\u5e8a\u836f\u7406\u5b66\u53ca\u7597\u6548\u6570\u636e\u4fc3\u8fdb\u4e86\u4e0eFDA\u5bcc\u6709\u6210\u6548\u7684\u5bf9\u8bdd\u3002\u83b7\u5f97FDA\u5bf9\u5173\u952e\u8ba1\u5212\u8981\u7d20\u7684\u8ba4\u53ef\u662f\u6211\u4eec\u5728\u7f8e\u56fd\u63a8\u8fdbIII\u671f\u8bd5\u9a8c\u7684\u5173\u952e\u91cc\u7a0b\u7891\u3002&quot;<\/p>\n<p>\u53c2\u8003\u8d44\u6599:<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tbody>\n<tr>\n<td class=\"prnpr2 prnpl2 prnsbtb0 prnrbrb0 prnsbbb0 prnsblb0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[1] Hyuna Sung, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185<br \/>Countries. CA CANCER J CLIN 2021;71:209\u2013249<br \/>[2] NCCN guideline for Gastric Cancer Version 2.2022<br \/>[3] Janjigian YY, Shitara K, Moehler M, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet 2021;398:27-40<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Osemitamab (TST001)\u6709\u671b\u6210\u4e3a\u5168\u7403\u7597\u6cd5\uff0c\u63d0\u5347HER2\u9634\u6027\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c\u60a3\u8005\u7684\u5f53\u524d\u6cbb\u7597\u6807\u51c6\u3002 \u7f8e\u56fd\u65b0\u6cfd\u897f\u5dde\u666e\u6797\u65af\u987f\u548c\u4e2d\u56fd\u82cf\u5dde2023\u5e7410\u67084\u65e5 \/\u7f8e\u901a\u793e\/ &#8212;&nbsp;\u521b\u80dc\u96c6\u56e2(06628.HK)\uff0c\u4e00\u5bb6\u5177\u5907\u751f\u7269\u836f\u54c1\u53d1\u73b0\u3001\u7814\u53d1\u3001\u5de5\u827a\u5f00\u53d1\u548c\u751f\u4ea7\u5168\u6d41\u7a0b\u6574\u5408\u80fd\u529b\u7684\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u5ba3\u5e03\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40(FDA)\u5df2\u6279\u51c6\u516c\u53f8\u5f00\u5c55Osemitamab (TST001)\u8054\u5408\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u53ca\u5316\u7597\u4f5c\u4e3aHER2\u9634\u6027\u3001CLDN18.2\u8868\u8fbe\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c(G\/GEJ)\u60a3\u8005\u4e00\u7ebf\u6cbb\u7597\u7684TranStar 301\u5168\u7403III\u671f\u5173\u952e\u6027\u8bd5\u9a8c\u3002\u83b7\u5f97\u8be5\u540c\u610f\u6807\u5fd7\u7740Osemitamab (TST001)\u7684\u5168\u7403\u5f00\u53d1\u83b7\u5f97\u91cd\u5927\u8fdb\u5c55\uff0c\u4e5f\u662f\u7ee72023\u5e747\u6708Osemitamab (TST001)\u7684III\u671f\u5173\u952e\u6027\u8bd5\u9a8c\u83b7\u4e2d\u56fd\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u836f\u54c1\u5ba1\u8bc4\u4e2d\u5fc3(CDE)\u548c\u97e9\u56fdMFDS\u6279\u51c6\u540e\u7684\u53c8\u4e00\u4e2a\u91cd\u8981\u91cc\u7a0b\u7891\u3002&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u8fd9\u4e00\u91cc\u7a0b\u7891\u6807\u5fd7\u7740Osemitamab (TST001)\u5728\u5411\u5168\u7403\u7597\u6cd5\u8fc8\u8fdb\u7684\u8fc7\u7a0b\u4e2d\u53d6\u5f97\u4e86\u91cd\u8981\u8fdb\u5c55\uff0c\u4ece\u800c\u63d0\u5347\u4e86HER2\u9634\u6027\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8(G\/GEJ)\u817a\u764c\u60a3\u8005\u7684\u5f53\u524d\u6cbb\u7597\u6807\u51c6\u3002\u901a\u8fc7\u7279\u5f02\u6027\u9776\u5411CLDN18.2\u5e76\u5c06\u5176\u8054\u5408\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u53ca\u5316\u7597\uff0cOsemitamab (TST001)\u6709\u671b\u91cd\u5851\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c\u7684\u6cbb\u7597\u6a21\u5f0f\u3002 \u80c3\u764c\u5728\u5168\u7403\u8303\u56f4\u5185\u4ecd\u7136\u662f\u4e00\u79cd\u5e38\u89c1\u764c\u75c7\uff0c\u4e8e2020\u5e74\u9020\u6210\u8d85\u8fc7\u4e00\u767e\u4e07\u5b97\u65b0\u75c5\u4f8b\uff0c\u4f30\u8ba1\u6709769,000\u4eba\u6b7b\u4ea1\uff08\u76f8\u5f53\u4e8e\u5168\u7403\u6bcf13\u4f8b\u6b7b\u4ea1\u75c5\u4f8b\u4e2d\u5c31\u67091\u4f8b\u6b7b\u4e8e\u80c3\u764c\uff09\uff0c\u5168\u7403\u53d1\u75c5\u7387\u6392\u540d\u7b2c\u4e94\uff0c\u6b7b\u4ea1\u7387\u6392\u540d\u7b2c\u56db1\u3002\u94c2\u7c7b\u548c\u6c1f\u5c3f\u5627\u5576\u8054\u5408\u7597\u6cd5\u662fHER2 \u9634\u6027\u665a\u671f\u80c3\u764c\u60a3\u8005\u7684\u4e3b\u8981\u5316\u7597\u65b9\u68482\u3002\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u88ab\u6279\u51c6\u4e0e\u5316\u7597\u8054\u5408\u7528\u4e8e\u665a\u671f\u6216\u8f6c\u79fb\u6027\u80c3\u764c\u60a3\u8005\u7684\u4e00\u7ebf\u6cbb\u7597\u3002\u5c3d\u7ba1\u6cbb\u7597\u7ed3\u679c\u6709\u6240\u6539\u5584\uff0c\u4f46\u63a5\u53d7\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u52a0\u5316\u7597\u7684\u60a3\u8005\u4e2d\u4f4d\u603b\u751f\u5b58\u671f\u4ecd\u5c11\u4e8e14\u4e2a\u67083\u3002 Osemitamab (TST001)\u662f\u7b2c\u4e8c\u4ee3\u9776\u5411CLDN18.2\u7684\u4eba\u6e90\u5316\u6297\u4f53\uff0c\u5177\u6709\u6539\u5584\u7684CLDN18.2\u7ed3\u5408\u4eb2\u548c\u529b\u548c\u589e\u5f3a\u7684\u6297\u4f53\u4f9d\u8d56\u6027\u7ec6\u80de\u6bd2\u6027\uff08ADCC\uff09\u3002\u5176\u5728\u5177\u6709\u5e7f\u6cdbCLDN18.2\u8868\u8fbe\u7684\u4e34\u5e8a\u524d\u80bf\u7624\u6a21\u578b\u4e2d\u663e\u793a\u51fa\u6297\u80bf\u7624\u6d3b\u6027\u3002 \u4e3a\u652f\u6301\u5168\u7403III\u671f\u8bd5\u9a8c\u7533\u8bf7\u53caFDA\u7684\u4e34\u5e8aII\u671f\u7ed3\u675f\u4f1a\u8bae(EOP2)\uff0c\u521b\u80dc\u96c6\u56e2\u5df2\u5728\u7f8e\u56fd\u53ca\u4e2d\u56fd\u540c\u65f6\u8fdb\u884c\u4e86Osemitamab (TST001)\u8054\u5408\u5316\u7597\u6216\u8054\u5408\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u4e0e\u5316\u7597\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5e76\u8bbe\u7f6e\u4e86\u591a\u4e2a\u5242\u91cf\u7ec4\uff0c\u4ee5\u4f18\u5316III\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5242\u91cf\u3002\u6b64\u5916\uff0c\u516c\u53f8\u8fd8\u4e0e\u7f8e\u56fd\u4e00\u5bb6\u7ecf\u9a8c\u4e30\u5bcc\u7684\u4f34\u968f\u8bca\u65ad\u5408\u4f5c\u4f19\u4f34\u5408\u4f5c\uff0c\u5171\u540c\u5f00\u53d1\u4e86\u4e00\u79cd\u53ef\u7279\u5f02\u6027\u8bc6\u522bCLDN18.2\u7684\u4f34\u968f\u8bca\u65ad\u8bd5\u5242\u76d2\u3002 \u4e8e2023 \u5e74ASCO \u5e74\u4f1a\u53ca2023 \u5e74ESMO GI \u4f1a\u8bae\u4e0a\uff0c\u521b\u80dc\u96c6\u56e2\u5448\u62a5\u4e86Osemitamab (TST001)\u8054\u5408CAPOX\u4f5c\u4e3a\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c\u4e00\u7ebf\u6cbb\u7597\u7684\u4ee4\u4eba\u9f13\u821e\u7684\u7597\u6548\u6570\u636e\u3002\u5728\u5242\u91cf\u9012\u589e\u53ca\u5242\u91cf\u6269\u5c55\u7ec4\u4e2d\uff0c\u5171\u670964\u540d\u60a3\u8005\u5165\u7ec4\u5e76\u63a5\u53d7Osemitamab (TST001)\u6cbb\u7597\uff0c\u5242\u91cf\u8303\u56f4\u4e3a1\u81f38mg\/kg Q3W\u3002\u7597\u6548\u6269\u5c55\u8981\u6c42CLDN18.2\u9633\u6027\uff08\u5373\u7528LDT\u65b9\u6cd5\u226510%\u80bf\u7624\u7ec6\u80de\u7684CLDN18.2 IHC\u819c\u67d3\u8272\u5f3a\u5ea6\u22651+\uff0c\u7b5b\u9009\u51fa\u7ea655%\u7684\u7b5b\u9009\u60a3\u8005\uff09\u3002\u6570\u636e\u663e\u793a\uff0c\u6240\u6709\u5242\u91cf\u7ec4\u7684\u9884\u8ba1\u4e2d\u4f4d\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\uff08DOR)\u4e3a9.9\u4e2a\u6708\uff0c\u4e2d\u4f4d\u65e0\u8fdb\u5c55\u751f\u5b58\u671f(PFS)\u4e3a9.5\u4e2a\u6708\u3002\u5728\u6269\u5c55\u9636\u6bb5\uff0c\u4ee56mg\/kg Q3W\u5242\u91cf\u6cbb\u7597\u768449\u540d\u60a3\u8005\u7684mDOR \u53camPFS\u6570\u636e\u5c06\u4e8e2023\u5e74ESMO\u4e0a\u5448\u62a5\u3002\u8be5\u7b49\u6570\u636e\u4ea6\u663e\u793a\uff0c\u53d7\u76ca\u4e8e\u5728\u6807\u51c6\u6cbb\u7597\u4e2d\u52a0\u5165Osemitamab (TST001)\u7684CLDN18.2\u9633\u6027\u60a3\u8005\u53ef\u80fd\u5360\u6240\u6709\u80c3\u764c\u6216\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u817a\u764c\u768455%\u4ee5\u4e0a\u3002 \u521b\u80dc\u96c6\u56e2\u5168\u7403\u836f\u7269\u5f00\u53d1\u6267\u884c\u526f\u603b\u88c1\uff0c\u9996\u5e2d\u533b\u5b66\u5b98Caroline Germa\u535a\u58eb\u8868\u793a\uff0c&quot;\u6211\u4eec\u5bf9EOP2\u4f1a\u8bae\u53d6\u5f97\u7684\u79ef\u6781\u6210\u679c\u611f\u5230\u9ad8\u5174\uff0c\u6211\u4eec\u63d0\u4ea4\u7684\u4e2d\u671f\u5b89\u5168\u6027\u3001\u4e34\u5e8a\u836f\u7406\u5b66\u53ca\u7597\u6548\u6570\u636e\u4fc3\u8fdb\u4e86\u4e0eFDA\u5bcc\u6709\u6210\u6548\u7684\u5bf9\u8bdd\u3002\u83b7\u5f97FDA\u5bf9\u5173\u952e\u8ba1\u5212\u8981\u7d20\u7684\u8ba4\u53ef\u662f\u6211\u4eec\u5728\u7f8e\u56fd\u63a8\u8fdbIII\u671f\u8bd5\u9a8c\u7684\u5173\u952e\u91cc\u7a0b\u7891\u3002&quot; \u53c2\u8003\u8d44\u6599: [1] Hyuna Sung, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185Countries.&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2023100407000096580\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-96580","post","type-post","status-publish","format-standard","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/96580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=96580"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/96580\/revisions"}],"predecessor-version":[{"id":96581,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/96580\/revisions\/96581"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=96580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=96580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=96580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}